[144] Ocular Therapeutix, Inc. SEC Filing

Rhea-AI Filing Summary

Ocular Therapeutix, Inc. (OCUL) filed a Form 144 reporting a proposed sale of 21,494 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $258,757.67. The filing shows 173,995,221 shares outstanding and an approximate sale date of 08/25/2025. The shares were acquired on 08/22/2025 by restricted stock vesting under a registered plan and payment/transfer is recorded as 08/22/2025.

The filer certifies no undisclosed material adverse information. No other sales in the past three months are reported. This is a routine notice of proposed sale under Rule 144 showing a short waiting period between vesting and the planned sale.

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for vested restricted stock; not a material transaction relative to outstanding shares.

The filing documents a proposed disposition of 21,494 shares valued at $258,757.67, representing a de minimis percentage of the 173,995,221 shares outstanding. The acquisition via restricted stock vesting and the close timing between vesting (08/22/2025) and proposed sale (08/25/2025) is consistent with executives or insiders liquidating vested awards. From a market-impact perspective this is likely immaterial given the small relative size and absence of other recent sales.

Corporate Governance Expert

TL;DR: Disclosure aligns with compliance expectations; signature attests no undisclosed material information.

This Form 144 contains the required broker, share count, aggregate value, acquisition method, and representation regarding material information. It notes restricted stock vesting as the acquisition source and records no other sales in the prior three months. The filing meets Rule 144 notice requirements and signals adherence to reporting protocols for insider transactions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	21494	258757.67	173995221	08/25/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/22/2025	Restricted stock vesting under a registered plan	Issuer			21494	08/22/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did OCUL report on Form 144?

The filing reports a proposed sale of 21,494 common shares valued at $258,757.67 to be executed via Morgan Stanley Smith Barney LLC around 08/25/2025.

How were the shares acquired according to the filing?

The shares were acquired on 08/22/2025 as restricted stock vesting under a registered plan and the payment/transfer date is listed as 08/22/2025.

Does the filing indicate other sales in the past three months for the seller?

No. The filing states "Nothing to Report" for securities sold during the past three months.

Who is the broker handling the proposed sale?

The broker named in the filing is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, New York, NY.

What does the signature representation state?

The filer represents by signing that they do not know any material adverse information about the issuer that has not been publicly disclosed.